{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CYP19A1", "bone metabolism", "gene polymorphism", "hyperandrogenism"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35743606", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "20"}], "Language": ["eng"], "ELocationID": ["3537", "10.3390/jcm11123537"], "Journal": {"ISSN": "2077-0383", "JournalIssue": {"Volume": "11", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "20"}}, "Title": "Journal of clinical medicine", "ISOAbbreviation": "J Clin Med"}, "ArticleTitle": "Association of the <i>CYP19A1</i> rs700518 Polymorphism with Selected Markers of Bone Metabolism in Women with Hyperandrogenism.", "Abstract": {"AbstractText": ["Hyperandrogenism is the most common endocrine disorder in women, characterized by an imbalance of normal estrogen and androgen levels in the blood. Androgens play an important role in the female body because they influence bone mineral density (BMD), body mass composition, muscle mass, mental state, and the regulation of sexual function. The reduced activity of aromatase, due to mutations in the <i>CYP19A1</i> gene, reduces the estrogen pool in favor of androgens. Clinically, aromatase deficiency causes hyperandrogenism in women. Therefore, the aim of the study was to assess the effect of the <i>CYP19A1</i> gene polymorphism on selected markers of bone metabolism and hormonal parameters in women with hyperandrogenism. The study group was comprised of 80 young women with hyperandrogenism who underwent measurements of bone mineral density (BMD), and determination of hormonal and metabolic parameters. Enzyme immunoassays were used to measure leptin, total sRANKL (free and bound RANKL), osteoprotegerin, and total 25-OH Vitamin D. An analysis of the <i>CYP19A1</i> gene polymorphisms was performed using the real-time PCR method. The GG genotype of the <i>CYP19A1</i> rs700518 polymorphism turned out to be associated with: FEI (Free Estradiol Index), SHGB concentration, estradiol concentration, and insulin concentration determined in the glucose tolerance test 60' compared to AG and AA genotypes. Patients with the AG genotype had a higher ratio of android to gynoid fat and a greater content of visceral adipose tissue. Higher visceral tissue content may reduce BMD. In conclusion, the study showed that the <i>CYP19A1</i> rs700518 polymorphism may be associated with the distribution of adipose tissue in young women with hyperandrogenism. These results suggest that patients with the AG genotype may develop osteoporosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University, 71-230 Szczecin, Poland."}], "LastName": "Uzar", "ForeName": "Izabela", "Initials": "I"}, {"Identifier": ["0000-0001-5455-8315"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibers and Medicinal Plants, 62-064 Plewiska, Poland."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Endocrinology, Metabolic Diseases and Internal Diseases, Pomeranian Medical University, 71-252 Szczecin, Poland."}], "LastName": "Sowi\u0144ska-Przepiera", "ForeName": "El\u017cbieta", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gynecology and Obstetrics, Collegium Medicum, University of Zielona G\u00f3ra, 65-001 Zielona G\u00f3ra, Poland."}], "LastName": "Pi\u0105tek", "ForeName": "Krzysztof", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University, 71-230 Szczecin, Poland."}], "LastName": "Przerwa", "ForeName": "Filip", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibers and Medicinal Plants, 62-064 Plewiska, Poland."}], "LastName": "Wolek", "ForeName": "Marlena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University, 71-230 Szczecin, Poland."}, {"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibers and Medicinal Plants, 62-064 Plewiska, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Clin Med", "NlmUniqueID": "101606588", "ISSNLinking": "2077-0383"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sowinska-Przepiera E., Chelstowski K., Friebe Z., Syrenicz A. Bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment\u2014A 4-year prospective study. Gynecol. Endocrinol. 2011;27:966\u2013970. doi: 10.3109/09513590.2011.569605.", "ArticleIdList": ["10.3109/09513590.2011.569605", "21500996"]}, {"Citation": "Liu J.H., Bill A.H. Stress-associated or functional hypothalamic amenorrhea in the adolescent. Ann. N. Y. Acad. Sci. 2008;1135:179\u2013184. doi: 10.1196/annals.1429.027.", "ArticleIdList": ["10.1196/annals.1429.027", "18574223"]}, {"Citation": "Bomba M., Gambera A., Bonini L., Peroni M., Neri F., Scagliola P., Nacinovich R. Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil. Steril. 2007;87:876\u2013885. doi: 10.1016/j.fertnstert.2006.09.011.", "ArticleIdList": ["10.1016/j.fertnstert.2006.09.011", "17274991"]}, {"Citation": "Sowinska-Przepiera E., Niedzielska M. Hiperandrogenizm u kobietjako problem kliniczny, diagnostycznyiterapeutyczny. Prz. Lek. 2018;75:405\u2013410."}, {"Citation": "Unluhizarci K., Kaltsas G., Kelestimur F. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur. J. Clin. Investig. 2012;42:86\u201394. doi: 10.1111/j.1365-2362.2011.02550.x.", "ArticleIdList": ["10.1111/j.1365-2362.2011.02550.x", "21623779"]}, {"Citation": "Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin. Endocrinol. Metab. 1986;15:213\u2013228. doi: 10.1016/S0300-595X(86)80021-4.", "ArticleIdList": ["10.1016/S0300-595X(86)80021-4", "3013468"]}, {"Citation": "Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., Dodson Michael M., et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 1994;15:342\u2013355.", "ArticleIdList": ["8076586"]}, {"Citation": "Chen S., Besman M.J., Sparkes R.S., Zollman S., Klisak I., Mohandas T., Hall P.F., Shively J.E. Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome. DNA. 1988;7:27\u201338. doi: 10.1089/dna.1988.7.27.", "ArticleIdList": ["10.1089/dna.1988.7.27", "3390233"]}, {"Citation": "Bulun S.E. Aromatase deficiency. Fertil. Steril. 2014;101:323\u2013329. doi: 10.1016/j.fertnstert.2013.12.022.", "ArticleIdList": ["10.1016/j.fertnstert.2013.12.022", "PMC3939057", "24485503"]}, {"Citation": "Kastelan D., Grubic Z., Kraljevic I., Duric K., Kardum I., Dusek T., Stingl K., Giljevic Z., Kerhin-Brkljacic V., Suchanek E., et al. Decreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: Preliminary data from the GOOS study. J. Endocrinol. Investig. 2007;30:465\u2013469. doi: 10.1007/BF03346329.", "ArticleIdList": ["10.1007/BF03346329", "17646720"]}, {"Citation": "Masi L., Becherini L., Gennari L., Amedei A., Colli E., Falchetti A., Farci M., Silvestri S., Gonnelli S., Brandi M.L. Polymorphism of the aromatase gene in postmenopausal Italian women: Distribution and correlation with bone mass and fracture risk. J. Clin. Endocrinol. Metab. 2001;86:2263\u20132269. doi: 10.1210/jc.86.5.2263.", "ArticleIdList": ["10.1210/jc.86.5.2263", "11344237"]}, {"Citation": "Praveen V.P., Ladjouze A., Sauter K.S., Pulickal A., Katharopoulos E., Trippel M., Perren A., Pandey A.V., Fl\u00fcck C.E. Novel CYP19A1 Mutations Extend the Genotype-Phenotype Correlation and Reveal the Impact on Ovarian Function. J. Endocr. Soc. 2020;4:bvaa030. doi: 10.1210/jendso/bvaa030.", "ArticleIdList": ["10.1210/jendso/bvaa030", "PMC7159065", "32318648"]}, {"Citation": "Sowers M.R., Wilson A.L., Kardia S.R., Chu J., Ferrell R. Aromatase Gene (CYP 19) Polymorphisms and Endogenous Androgen Concentrations in a Multiracial/Multiethnic, Multisite Study of Women at Midlife. Am. J. Med. 2006;119:23\u201330. doi: 10.1016/j.amjmed.2006.07.003.", "ArticleIdList": ["10.1016/j.amjmed.2006.07.003", "16949385"]}, {"Citation": "Napoli N., Rastelli A., Ma C., Yarramaneni J., Vattikutti S., Moskowitz G., Giri T., Mueller C., Kulkarny V., Qualls C., et al. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer. Bone. 2013;55:309\u2013314. doi: 10.1016/j.bone.2013.04.021.", "ArticleIdList": ["10.1016/j.bone.2013.04.021", "PMC3966714", "23643682"]}, {"Citation": "Kami\u0144ski A., Bogacz A., G\u00f3rska-Paukszta M., Seremak-Mrozikiewicz A., Czerny B. Correlation of rs749292 and rs700518 polymorphisms in the aromatase gene (CYP19A1) with osteoporosis in postmenopausal Polish women. Adv. Clin. Exp. Med. 2019;28:1067\u20131071. doi: 10.17219/acem/103803.", "ArticleIdList": ["10.17219/acem/103803", "30855728"]}, {"Citation": "Riancho J.A., Sa\u00f1udo C., Valero C., Pipa\u00f3n C., Olmos J.M., Mijares V., Fern\u00e1ndez-Luna J.L., Zarrabeitia M.T. Association of the aromatase gene alleles with BMD: Epidemiological and functional evidence. J. Bone. Miner. Res. 2009;24:1709\u20131718. doi: 10.1359/jbmr.090404.", "ArticleIdList": ["10.1359/jbmr.090404", "19419293"]}, {"Citation": "Ma H.J., Fu S.C., Xiao A., Cai W.K., Wang P., Shen M.L., Li Z.Y., He G.H. The associations of CYP19A1 rs700518 polymorphism with bone mineral density and risk of osteoporosis: A meta-analysis. Gynecol. Endocrinol. 2020;36:626\u2013631. doi: 10.1080/09513590.2020.1727431.", "ArticleIdList": ["10.1080/09513590.2020.1727431", "32070153"]}, {"Citation": "Somner J., McLellan S., Cheung J., Mak Y.T., Frost M.L., Knapp K.M., Wierzbicki A.S., Wheeler M., Fogelman I., Ralston S.H., et al. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: Association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J. Clin. Endocrinol. Metab. 2004;89:344\u2013351. doi: 10.1210/jc.2003-030164.", "ArticleIdList": ["10.1210/jc.2003-030164", "14715870"]}, {"Citation": "Junying S., Zhang Q. Association of cytochrome p450 gene CYP19 polymorphism with bone mineral density in postmenopausal Anhui Province women. Anhui. Med. Pharm. J. 2010;14:548\u2013550."}, {"Citation": "Aguirre L.E., Colleluori G., Robbins D., Dorin R., Shah V.O., Chen R., Jan I.Z., Qualls C., Villareal D.T. Armamento-Villareal, R. Bone and body composition response to testosterone therapy vary according to polymorphisms in the CYP19A1 gene. Endocrine. 2019;65:692\u2013706. doi: 10.1007/s12020-019-02008-6.", "ArticleIdList": ["10.1007/s12020-019-02008-6", "PMC8077393", "31325085"]}, {"Citation": "Ebrahimi A., Rahimi Z., Ghadami Z., Shakiba E., Rahimi Z., Akbari M., Shafiei M., Bahrehmand F., Vaisi-Raygani A., Naseri R. Association between CYP19A<G rs700518 Polymorphism with Acne Vulgaris and its Severity: Influence on Sex Hormones Level. Int. J. Mol. Cell. Med. 2019;8:162\u2013168.", "ArticleIdList": ["PMC7081083", "32215267"]}, {"Citation": "Giorgino F., Laviola L., Eriksson J.W. Regional differences of insulin action in adipose tissue: Insights from in vivo and in vitro studies. Acta. Physiol. Scand. 2005;183:13\u201330. doi: 10.1111/j.1365-201X.2004.01385.x.", "ArticleIdList": ["10.1111/j.1365-201X.2004.01385.x", "15654917"]}, {"Citation": "Tchernof A., B\u00e9langer C., Morisset A.S., Richard C., Mailloux J., Laberge P., Dupont P. Regional differences in adipose tissue metabolism in women: Minor effect of obesity and body fat distribution. Diabetes. 2006;55:1353\u20131360. doi: 10.2337/db05-1439.", "ArticleIdList": ["10.2337/db05-1439", "16644692"]}, {"Citation": "Napoli N., Rastelli A., Ma C., Yarramaneni J., Vattikutti S., Moskowitz G., Giri T., Mueller C., Kulkarny V., Qualls C., et al. Genetic Polymorphism at Val80 (rs700518) of the CYP19A1 Gene is Associated with Body Composition Changes in Women on Aromatase Inhibitors for ER (+) Breast Cancer. Pharmacogenet. Genom. 2015;25:377\u2013381. doi: 10.1097/FPC.0000000000000146.", "ArticleIdList": ["10.1097/FPC.0000000000000146", "PMC4498982", "26049585"]}, {"Citation": "Samouda H. Commentary: Anthropometric Indicators as a Tool for Diagnosis of Obesity and Other Health Risk Factors: A Literature Review. Front. Psychol. 2021;12:750613. doi: 10.3389/fpsyg.2021.750613.", "ArticleIdList": ["10.3389/fpsyg.2021.750613", "PMC8481814", "34603167"]}, {"Citation": "Brown J.C., Harhay M.O., Harhay M.N. Anthropometrically-predicted visceral adipose tissue and mortality among men and women in the third national health and nutrition examination survey (NHANES III) Am. J. Hum. Biol. 2017;29:e22898. doi: 10.1002/ajhb.22898.", "ArticleIdList": ["10.1002/ajhb.22898", "PMC5241265", "27427402"]}, {"Citation": "Chen Z., Wang O., Nie M., Elison K., Zhou D., Li M., Jiang Y., Xia W., Meng X., Chen S., et al. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: Effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism. Mol. Cell. Endocrinol. 2015;399:32\u201342. doi: 10.1016/j.mce.2014.09.016.", "ArticleIdList": ["10.1016/j.mce.2014.09.016", "PMC4457386", "25301327"]}, {"Citation": "Santen R.J., Brodie H., Simpson E.R., Siiteri P.K., Brodie A. History of aromatase: Saga of an important biological mediator and therapeutic target. Endocr. Rev. 2009;30:343\u2013375. doi: 10.1210/er.2008-0016.", "ArticleIdList": ["10.1210/er.2008-0016", "19389994"]}, {"Citation": "Maffei L., Murata Y., Rochira V., Tubert G., Aranda C., Vazquez M., Clyne C.D., Davis S., Simpson E.R., Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: Effects of testosterone, alendronate, and estradiol treatment. J. Clin. Endocrinol. Metab. 2004;89:61\u201370. doi: 10.1210/jc.2003-030313.", "ArticleIdList": ["10.1210/jc.2003-030313", "14715828"]}, {"Citation": "Oz O.K., Millsaps R., Welch R. Expression of aromatase in the human growth plate. J. Mol. Endocrinol. 2001;27:249\u2013253. doi: 10.1677/jme.0.0270249.", "ArticleIdList": ["10.1677/jme.0.0270249", "11564607"]}, {"Citation": "Liu H.J., Yan J., Li Y., Zhou F.Y., Su X.D., Fan H.J., Bai J., Zhang G.Z. Low Aromatase Activity and Estradiol/Sex Hormone Binding Globulin Ratio are Associated with Total Hip Bone Mineral Density and the Presence of Osteoporosis: A Study in Chinese Postmenopausal Women. Horm. Metab. Res. 2018;50:65\u201372. doi: 10.1055/s-0043-116672.", "ArticleIdList": ["10.1055/s-0043-116672", "29329467"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "5"}, {"Year": "2022", "Month": "6", "Day": "14"}, {"Year": "2022", "Month": "6", "Day": "15"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "1", "Minute": "25"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["35743606", "PMC9224995", "10.3390/jcm11123537", "jcm11123537"]}}], "PubmedBookArticle": []}